2016 International Congress Archives - Page 17 of 207

12:30pm-2:00pm: Do subjective ratings of the Parkinson’s disease sleep scale-2 converge with results from polysomnography in early Parkinson’s disease? – A report from the DeNoPa cohort

F. Sixel-Döring, J. Zimmermann, M.L. Muntean, B. Mollenhauer, C. Trenkwalder (Kassel, Germany)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Do-not-resuscitate utilization in inpatient Parkinson’s disease in the United States

A. Mahajan, A. Patel, G. Nadkarni, C. Sidiropoulos (Detroit, MI, USA)

Quality of life/caregiver burden in movement disorders · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Does body mass index influence outcome of deep brain stimulation in Parkinson’s patients?

H. Abboud, G. Genc, D. Reyes, N.R. Thompson, R. Cerejo, K. Wilson, A. Ahmed, M. Gostkowski, A. Machado, H.H. Fernandez (Cleveland, OH, USA)

Surgical therapy: Parkinson's disease · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Does GPi-DBS help non motor symptoms in cervical dystonia patients? A retrospective study of 17 patients

L. Lowry, B. Hammersley, M. Bonello, P. Byrne, N.A. Fletcher, J.O. Farah, P.R. Eldridge, S.H. Alusi (Liverpool, United Kingdom)

Surgical therapy: Other movement disorders · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Does link between fatigue syndrome and camptocormia in patients with Parkinson’s disease exist?

V. Datieva, O. Levin (Moscow, Russia)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Dopamine transporter, depression and anxiety differences between tremor-predominant and non-tremulous PD are already evident within 2 years of PD diagnosis

Q. Hu, F. Zhou, C.P. Jedynak, L.S. Rosenthal, Z. Mari, B.M. Jedynak (Baltimore, MD, USA)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Dophaminergic therapy and its influence on the olfactory function of patients with Parkinson’s disease

O. Izhboldina, I. Zhukova, N. Zhukova, V. Alifirova, A. Latypova, M. Nikitina, Y. Mironova (Tomsk, Russia)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Dorsal simultanagnosia as a cortical sign in the tauopathy spectrum

B. Bergmans, O. Deryck, R. Bruffaerts (Brugge, Belgium)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Double-blind, placebo-controlled trial of a fermented milk containing multiple probiotic strains and prebiotic fiber for constipation associated with Parkinson’s disease

E. Cereda, C. Pacchetti, C. Bolliri, E. Cassani, L. Iorio, C. Pusani, G. Pinelli, G. Privitera, I. Cesari, S.A. Faierman, R. Caccialanza, G. Pezzoli, M. Barichella (Pavia, Italy)

Parkinson's disease: Non-motor symptoms · Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm: Drug induced parkinsonism: Role of functional imaging and follow up

A.S. Shetty, H.J. Shah, V.R. Lele, P.M. Wadia (Mumbai, India)

Parkinsonism, MSA, PSP (secondary and parkinsonism-plus) · Exhibit Hall located in Hall B, Level 2